Argenx’s Autoimmune Disease Blockbuster-In-Waiting Gets FDA Decision Date

Myasthenia Gravis Is First Target

Myasthenia gravis
Myasthenia gravis causes muscle weakness, typically affecting the eyes and face.

More from Business

More from Scrip